Similar trends were seen 3–6 months following treatment initiation, where C and combination RT & C also had higher IRR of PBC compared to RT, older age was associated with a higher IRR of PBC, and breast cancer had the lowest IRR of PCB compared to all other diagnoses. This evidence concerns the gene DLAT and breast cancer.